MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 195 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,452,690 | -81.4% | 545,269 | -76.9% | 0.02% | -79.7% |
| Q2 2023 | $29,368,585 | +16.3% | 2,362,718 | +31.1% | 0.07% | +2.8% |
| Q1 2023 | $25,248,948 | +13.4% | 1,802,209 | +15.8% | 0.07% | +2.9% |
| Q4 2022 | $22,273,043 | +62.1% | 1,556,467 | +189.1% | 0.07% | +48.9% |
| Q3 2022 | $13,743,000 | -22.3% | 538,294 | -13.5% | 0.05% | -19.0% |
| Q2 2022 | $17,679,000 | -20.8% | 622,272 | -1.7% | 0.06% | -12.1% |
| Q1 2022 | $22,323,000 | +30.9% | 632,921 | +55.6% | 0.07% | +83.3% |
| Q4 2021 | $17,048,000 | +1069.3% | 406,880 | +1269.6% | 0.04% | +1100.0% |
| Q3 2021 | $1,458,000 | -92.0% | 29,708 | -93.2% | 0.00% | -92.9% |
| Q2 2021 | $18,323,000 | +131.4% | 439,076 | +97.6% | 0.04% | +100.0% |
| Q1 2021 | $7,919,000 | -2.0% | 222,206 | -22.9% | 0.02% | -8.7% |
| Q4 2020 | $8,084,000 | – | 288,198 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |